NASDAQ:BBNX Beta Bionics (BBNX) Stock Price, News & Analysis $13.59 +0.43 (+3.27%) As of 07/18/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Beta Bionics Stock (NASDAQ:BBNX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Beta Bionics alerts:Sign Up Key Stats Today's Range$13.28▼$14.2750-Day Range$12.53▼$19.5552-Week Range$8.89▼$24.50Volume337,570 shsAverage Volume460,182 shsMarket Capitalization$589.21 millionP/E RatioN/ADividend YieldN/APrice Target$23.44Consensus RatingModerate Buy Company Overview Beta Bionics, Inc. is a medical technology company focused on the development and commercialization of automated insulin delivery systems for people with insulin-dependent diabetes. The company’s core mission is to simplify glycemic management through advanced robotics and algorithm-driven platforms. Beta Bionics leverages proprietary adaptive control algorithms to continuously adjust insulin dosing in real time, aiming to reduce hypoglycemic and hyperglycemic events while easing the burden of daily diabetes management. The company’s lead product candidate, the iLet Bionic Pancreas System, integrates wearable hardware with a bi-hormonal or insulin-only configuration and communicates seamlessly with a disposable infusion set. In clinical trials, the iLet system has demonstrated the ability to autonomously manage blood glucose levels with minimal user input, drawing upon years of research collaborations with Massachusetts General Hospital and Boston University. Beta Bionics is actively pursuing regulatory approvals in the United States and Europe, positioning the iLet platform for broad adoption among adults and pediatrics with type 1 diabetes. Founded in 2015 and headquartered in Boston, Massachusetts, Beta Bionics operates research and development facilities in key biotech hubs across North America and Europe. The company has attracted strategic partnerships and grant funding from leading diabetes advocacy groups, academic institutions, and technology firms. Under the leadership of Chief Executive Officer Justin McAnear and co-founder Dr. Edward Damiano—an engineer and diabetes technology pioneer—Beta Bionics continues to expand its clinical program and manufacturing capabilities. The management team is supported by a board of directors and medical advisory board comprising endocrinologists, engineers, and patient advocates dedicated to advancing closed-loop diabetes solutions.AI Generated. May Contain Errors. Read More Receive BBNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter. Email Address BBNX Stock News HeadlinesBeta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 - MorningstarJuly 4, 2025 | morningstar.comMBeta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 - Seeking AlphaJuly 4, 2025 | seekingalpha.comHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation. | Paradigm Press (Ad)Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic PancreasJuly 4, 2025 | msn.comBeta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025July 2, 2025 | globenewswire.comBeta Bionics, Inc. (BBNX) Income Statement - Yahoo FinanceJuly 1, 2025 | finance.yahoo.comBeta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone SensorJune 19, 2025 | globenewswire.comBeta Bionics stock initiated with Buy rating at Truist SecuritiesJune 17, 2025 | investing.comSee More Headlines BBNX Stock Analysis - Frequently Asked Questions How have BBNX shares performed this year? Beta Bionics' stock was trading at $23.81 at the beginning of the year. Since then, BBNX stock has decreased by 42.9% and is now trading at $13.59. How were Beta Bionics' earnings last quarter? Beta Bionics, Inc. (NASDAQ:BBNX) released its earnings results on Tuesday, May, 6th. The company reported ($0.52) EPS for the quarter, missing analysts' consensus estimates of ($0.51) by $0.01. Read the conference call transcript. When did Beta Bionics IPO? Beta Bionics (BBNX) raised $204 million in an IPO on Thursday, January 30th 2025. The company issued 12,000,000 shares at a price of $17.00 per share. When does Beta Bionics' lock-up period expire? Beta Bionics's lock-up period expires on Tuesday, July 29th. Beta Bionics had issued 12,000,000 shares in its initial public offering on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period. Who are Beta Bionics' major shareholders? Top institutional shareholders of Beta Bionics include Palumbo Wealth Management LLC (0.07%). Insiders that own company stock include Hadley Harbor Aggre Wellington, Mike Mensinger, Steven Jon Russell, Stephen Feider and Mark Hopman. View institutional ownership trends. How do I buy shares of Beta Bionics? Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/06/2025Today7/19/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:BBNX Previous SymbolNASDAQ:BBNX CIK1674632 WebN/A Phone(949) 427-7785FaxN/AEmployees294Year FoundedN/APrice Target and Rating Average Price Target for Beta Bionics$23.44 High Price Target$30.00 Low Price Target$16.00 Potential Upside/Downside+72.5%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio15.88 Quick Ratio14.93 Sales & Book Value Annual Sales$65.12 million Price / Sales9.05 Cash FlowN/A Price / Cash FlowN/A Book Value($5.72) per share Price / Book-2.38Miscellaneous Outstanding Shares43,360,000Free FloatN/AMarket Cap$589.26 million OptionableN/A BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:BBNX) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.